re not trivial -- the more thought and effort you put into doing this exercise, the more you will get out of it.
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
PART 1: Gather "data"
For the next 7 days, keep an eye out for the following situations each day:
- When during the day did you i
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
itiate a conversation with a "stranger" (i.e. someone you didn't know)?
What was the situation or context? For instance, were you in thets. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
grocery store, the train station, an airplane, etc.?
What led you to initiate the conversation? For instance, did you need information (ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
.g. directions), were you curious about something, did you have information you wanted to offer the other person, etc.?
How did this feedd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
conversation for you? (E.g. comfortable, awkward, neutral, etc.) Why is this?
Jot down what you notice at the end of each day, so you
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
an remember it.
PART 2: Look at your "data"At the end of the week, look through your notes:
- What patterns do you noti
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ce about when and how you initiate conversations?
What allows you to initiate conversations?
What specifically makes you to fet?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
l comfortable or uncomfortable in such conversations?
How are these situations similar or different from business networking conversatioping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
s?
PART 3: Action PlanNow use this information to your advantage.
- What did you learn about yourself and how
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
you engage in conversations with "strangers", from doing this exercise?
How will you use this information in the context of business net.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
orking?
As I said, it can be a very powerful tool for you, if you do actually do this exercise.
So if this topic is of importance to y
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
u, invest the time to do this seriously. I guarantee you will see improvements in your ability to converse with people. Good luck
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products